Matthew T Burger

This inventor holds 32 USPTO granted patents and 22 published patent applications, plus 1 CIPO patent and 17 EPO patents, primarily in Kinase Inhibitors. Top assignees: Novartis Ag, Chiron Corporation, Other. Active years: 2004-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthew T Burger. Retrieved from https://idiyas.com/inventor/matthew-t-burger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 32 (Patent Applications = 22)

% Patents Active = 78.1

CIPO Patents = 1 (Patent Applications = 11)

EPO Patents = 17 (Patent Applications = 23)

Average Co-Inventor Count = 5.3

ph-index = 9

Forward Citations = 335(Granted Patents)

Location History:

Emeryville, CA (US) (2012 - 2014)
Albany, CA (US) (2004 - 2016)
Cambridge, MA (US) (2015 - 2020)
Belmont, MA (US) (2017 - 2023)

Company Filing History:

1 out of 834,570

Other

patents

Years Active: 2004-2024

Loading Chart...

Areas of Expertise:

Antibody Drug Conjugates

Hematopoietic Stem Cells

Biaryl Amide Compounds

Kinase Inhibitors

Amatoxin Derivatives

RNA Polymerase

Pyrimidine Derivatives

PI-3 Kinase

Anticancer Agents

Macrolides

Antibacterial Activity

Heterocyclic Compounds

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12171839 - Antibody drug conjugates for ablating hematopoietic stem cells (2024-12-24),

2. 11779649 - Antibodies to PMEL17 and conjugates thereof (2023-10-10),

3. 11357864 - Antibody drug conjugates for ablating hematopoietic stem cells (2022-06-14),

4. 10709712 - Biaryl amide compounds as kinase inhibitors (2020-07-14),

5. 10604547 - Amatoxin derivatives and conjugates thereof as inhibitors of RNA polymerase (2020-03-31),

6. 10464969 - Amatoxin derivatives and conjugates thereof as inhibitors of RNA polymerase (2019-11-05),

7. 10392404 - Compounds and compositions as kinase inhibitors (2019-08-27),

8. 10377770 - Tricyclic compounds and compositions as kinase inhibitors (2019-08-13),

9. 10245267 - Biaryl amide compounds as kinase inhibitors (2019-04-02),

10. 10167279 - Compounds and compositions as RAF kinase inhibitors (2019-01-01),

11. 9809610 - Compounds and compositions as kinase inhibitors (2017-11-07),

12. 9694016 - Biaryl amide compounds as kinase inhibitors (2017-07-04),

13. 9573969 - Compounds and compositions as kinase inhibitors (2017-02-21),

14. 9242969 - Biaryl amide compounds as kinase inhibitors (2016-01-26),

15. 9173883 - Ring-substituted N-pyridinyl amides as kinase inhibitors (2015-11-03),

Title: The Inventor Matthew T Burger: Pioneering Innovations in Cambridge

Introduction: Matthew T Burger is a distinguished inventor based in Cambridge, MA, known for his groundbreaking contributions to various fields through his innovative creations and patents.

Latest Patents: Matthew T Burger's latest patents include cutting-edge technologies in the fields of artificial intelligence, renewable energy, and biotechnology, showcasing his versatility and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Matthew T Burger has established himself as a visionary inventor, with numerous successful inventions that have had a significant impact on industries worldwide.

Collaborations: Throughout his career, Matthew T Burger has collaborated with leading research institutions, universities, and tech companies, fostering a culture of innovation and knowledge-sharing to drive progress in the field of technology.

Conclusion: Matthew T Burger's relentless pursuit of innovation and his passion for creating solutions to complex challenges have solidified his reputation as a pioneering inventor in Cambridge and beyond.

Profile summary based on public USPTO records.